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Abstract 
Kisspeptin is a hypothalamic peptide 
hormone, which plays a crucial role in 
puberty and fertility control by stimulating 
the release of gonadotrophin-releasing 
hormone, which in turn stimulates the 
release of luteinizing hormone and follicle 
stimulating hormone. It also interacts with 
neuropeptides neurokinin B and dynorphin 
A, and is under negative and positive 
feedback influences relayed by gonadal sex 
steroids. Loss of kisspeptin signalling results 
in hypogonadotrophic hypogonadism and 
impaired puberty.  Kisspeptin expression 
and secretion is also affected by metabolic 
status and stress. Several studies have 
indicated a potential role for kisspeptin in 
the treatment of disorders causing 
hypogonadotrophic hypogonadism. This 
review aims to summarize the importance of 
kisspeptin and its role in the hypothalamic-
pituitary-gonadal axis. 
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Introduction 
Kisspeptin is a hypothalamic peptide 
encoded by the KISS1 gene, which is found 
on chromosome 1q32, and is a powerful 
stimulator of the hypothalamic-pituitary-
gonadal (HPG) axis. It is involved in 
puberty onset and fertility control,1 and 
appears to be important for sexual 
development and differentiation in the early 
postnatal period, possibly through regulation 
of postnatal testosterone secretion.2 It acts 
upstream to gonadotrophin-releasing 
hormone (GnRH) and is cleaved from a 145-
amino acid precursor peptide into a 54-
amino acid peptide, which can be further 
cleaved into 14, 13 and 10-amino acid 
peptides. These carboxy-terminal RF-amide 
peptides are collectively called kisspeptins.1
Kisspeptin binds to the G-protein 
coupled receptor 54 or KISS1 receptor 
(KISS1R in humans/Kiss1r in rodents), 
expressed on GnRH neurons (also widely 
expressed within both cortical and 
subcortical regions and peripherally). It 
stimulates the pulsatile secretion of GnRH 
from GnRH neurons into the portal 
circulation, which will then stimulate the 
release of luteinizing hormone (LH) and 
follicle stimulating hormone (FSH) from the 
gonadotrophs in the anterior pituitary.1 
Kisspeptin neurons and sexual 
dimorphism 
In humans, kisspeptin neurons reside in 
the hypothalamic rostral preoptic area, in the 
infudibular (arcuate) nucleus, in the anterior 
parvocellular and magnocellular 
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subdivisions of the paraventricular nucleus 
and in the ventral and rostral periventricular 
hypothalamic nucleus.3 Infudibular and 
rostral kisspeptin neurons are in close 
apposition with GnRH neurons.  Kisspeptin 
neurons in the infudibular nucleus also 
express neurokinin B and dynorphin A, and 
are thus called KNDy neurons. Neurokinin 
B and dynorphin A autosynaptically control 
kisspeptin pulsatile secretion and thus 
GnRH release, by binding to the neurokinin 
B receptor (stimulatory) and kappa opioid 
peptide receptor (inhibitory) respectively, 
which are found on KNDy cells.  GnRH 
neurons do not express the oestrogen, 
progesterone or androgen receptors, which 
are however found on KNDy neurons. This 
suggests that KNDy neurons are responsible 
for relaying sex hormone negative and 
positive feedback, and thus regulating 
pulsatile kisspeptin release.1 The oestrogen 
receptor alpha (ERα) is fundamental for 
positive feedback, but was not found to be 
important for negative feedback on 
GnRH/LH secretion in adult female mice.4   
Females have appreciably more 
kisspeptin fibres and cell bodies in the 
infudibular nucleus as well as a significantly 
greater number of kisspeptin fibres in the 
ventral periventricular area compared to 
men.  In addition, expression of kisspeptin 
cell bodies in the rostral periventricular zone 
is seen in females only.1 This greater 
number of kisspeptin neurons in females 
will allow them to secrete more kisspeptin, 
which will enable them to produce the LH 
surge.2  Kisspeptin can reset the GnRH 
pulse generator in men i.e. kisspeptin can 
induce an LH pulse regardless of the timing 
of previous endogenous pulses.1 This is not 
seen in women across the different 
menstrual cycle phases, which could be due 
to changes in the sex hormone levels along 
the cycle.  Different kisspeptin responses 
depending on the menstrual cycle phase 
were noted in the study by Chan et al, and it 
appeared that kisspeptin tone was greater in 
the early follicular phase in contrast to the 
rest of the cycle phases.5   
 
Kisspeptin and the reproductive axis 
Kisspeptin’s effect on LH secretion is 
greater, often causing a 2 to 3-fold rise in 
most circumstances with a robust increase in 
both pulse frequency and amplitude, while 
its effect on FSH release is of a lower 
magnitude and less consistent.6-9 The 
gonadotrophin secretory pattern difference 
in response to kisspeptin could be due to 
variations in the secretory pattern between 
LH and FSH, being more constitutive for 
FSH; differences in the effect of kisspeptins 
on the GnRH secretory pattern, where 
induction of high frequency GnRH pulses 
will preferentially stimulate LH; and 
differences in regulatory influences of 
gonadal peptides such as inhibins, which 
regulate FSH release.10 
Kisspeptin neurons in the infudibular 
nucleus were found to become 
hypertrophied and harboured more KISS1 
messenger ribonucleic acid (mRNA) in post-
menopausal women compared to pre-
menopausal women,11 with increased 
expression of neurokinin B12 and lack of 
dynorphin A signalling.1 In a recent study, 
the number of kisspeptin-immunoreactive 
neurons within the infudibular nucleus of 
humans was found to be significantly higher 
in the infant/prepubertal and elderly (58-90 
year olds) periods rather than during the 
adult period (22-44 year olds).13 This means 
that oestrogen (or testosterone in males) 
suppresses kisspeptin and neurokinin B 
expression and release, whereas dynorphin 
A would be upregulated through negative 
feedback on the KNDy neurons, leading to a 
reduction in tonic GnRH and gonadotrophin 
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release, as occurs during the pre-ovulatory 
follicular phase.1 Only a partial inhibition of 
KISS1 mRNA was noted in sheep following 
progesterone replacement.10  
A change to positive feedback, which is 
associated with an increase in the oestrogen 
levels, occurs in the late follicular phase to 
induce the LH surge and ovulation.1 Many 
studies have shown that kisspeptin is 
essential for the LH surge. KISS1 mRNA 
increased in the anteroventral periventricular 
(AVPV) nucleus of ovariectomized rats at 
the time of the oestrogen and progesterone 
induced LH surge.14 Exogenous kisspeptin 
induced oocyte maturation and an LH surge 
during an FSH/GnRH antagonist in-vitro 
fertilisation protocol.15 Moreover, KISS1 
and Kiss1r knock-out (KO) mice fail to 
mount this pre-ovulatory LH surge.16 An 
intrinsic circadian Kiss-clock in the 
hypothalamic AVPV nucleus of female mice 
acting in combination with the 
suprachiasmatic nucleus may be leading to a 
circadian pattern of kisspeptin gene 
expression and neuronal activation in 
females.17 However, this circadian activation 
of kisspeptin neurons was found to rely on 
the presence of oestrogen, indicating that the 
LH surge is oestrogen dependent.2,17 
Changes in neurokinin B and dynorphin A 
levels may also contribute to the kisspeptin 
mediated LH surge.1 A recent study has 
demonstrated that the positive feedback of 
progesterone is likewise required for the 
kisspeptin neuronal activation and induction 
of the LH surge.18
KISS1 and KISS1R genes were noted 
to be expressed in pituitary gonadotrophs, 
while gonadotrophins (LH more than FSH) 
were secreted from pituitary explants on 
treatment with kisspeptin, indicating that 
kisspeptin may directly stimulate the release 
of LH and FSH from gonadotrophs.19-20 
However, the principal mechanism of 
gonadotrophin secretion still appears to be 
through stimulation of GnRH.21
Kisspeptin may also have a role in 
direct signalling on the ovary. This is 
suggested by a study done in mice where 
haplo-insufficiency of the Kiss1r resulted in 
a premature deterioration of the ovulatory 
rate as well as progressive loss of pre-antral 
and antral follicles and oocytes, resulting in 
a decline in fertility, atrophic ovaries and a 
state of premature ovarian failure. A 
decrease in ovarian Kiss1r mRNA 
expression was noted in the absence of a 
decline in gonadotrophins.  FSH actually 
increased due to follicular loss.  On the other 
hand, Kiss1r null mice, which have arrested 
follicular development and are anovulatory, 
lacked normal ovulatory responses on 
standard gonadotrophin priming.22 
Moreover, KISS1 and KISS1R mRNA have 
been found to be expressed in human 
gonads. Some studies in rats have shown 
that ovarian KISS1 expression increases 
during puberty and prior to ovulation under 
the influence of gonadotrophins, with a 
possible role of locally produced ovarian 
kisspeptin in ovulatory regulation.10 
Kisspeptin has also been shown to potentiate 
the effect of human chorionic gonadotrophin 
on testosterone release from the testes, and it 
can increase spermatozoa motility and 
fertilization capacity.23
Role of kisspeptin in puberty 
Inactivating mutations or KO of 
kisspeptin or its receptor result in 
hypogonadotrophic hypogonadism (HH) as 
well as impaired puberty/sexual maturation 
and infertility,2,24-25 while activating 
mutations or administration of exogenous 
kisspeptin result in precocious puberty.26-28  
Loss of kisspeptin (or its receptor) is 
responsible for approximately 2% of HH 
cases in humans.29  In a study done in mice, 
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there is an increase in the amount of GnRH 
neurons which depolarise in response to 
kisspeptin, from 27% in juvenile, to 44% in 
prepubertal, to >90% in adult mice, which 
means that GnRH neurons become more 
sensitive to kisspeptin during puberty.  
KISS1 mRNA increased from juvenile to 
adult mice in the AVPV nucleus, suggesting 
an increase in kisspeptin tone.30   
Kiss1r mRNA expression is also 
increased,31 which may play an important 
role in puberty by increasing the sensitivity 
of GnRH neurons to kisspeptin.  Increase in 
Kiss1r expression appears to occur earlier in 
female than in male rats, providing a 
possible explanation for earlier puberty in 
females.2  Furthermore, during puberty, 
there is an increase in the number of 
kisspeptin neurons and synaptic contacts 
with GnRH neurons.10, 32 In mice, the 
activation of kisspeptin expression during 
puberty appears to be driven by oestrogen; 
therefore, it appears that kisspeptin may 
require some degree of ovarian activation, 
which however, may not be the case in 
humans.10 In a study by Guerriero et al, the 
response of GnRH to kisspeptin was noted 
to switch from ovarian steroid independent 
(pre-pubertal) to dependent during puberty 
in female rhesus monkeys.33 A recent study 
has shown that the leptin - alpha-melanocyte 
stimulating hormone - kisspeptin - GnRH 
neuronal pathway in rodent models is 
involved in the metabolic control of 
puberty.34  Because of the greater amount of 
adipose tissue present close to puberty, more 
leptin would be secreted leading to 
kisspeptin release.35 
 
Kisspeptin - link between reproduction 
and metabolic status 
Reproduction requires sufficient 
amount of energy stores as it is highly 
metabolically demanding.32 Kisspeptin is 
regulated by metabolic signals (e.g leptin, 
ghrelin and neuropeptide Y) and may sense 
energy stores, which then influences the 
pulsatile release of GnRH, thus providing a 
connection between nutritional/metabolic 
status and reproduction.  Fasting and chronic 
undernutrition are associated with reduced 
kisspeptin and neurokinin B expression.1 In 
contrast, prepubertal rats given a high fat 
diet, showed increased kisspeptin and 
neurokinin B expression as well as LH 
pulsatility, leading to precocious puberty.  
Kisspeptin expression is decreased in leptin 
deficiency or leptin receptor ablation, where 
gonadotrophin levels improve upon leptin or 
kisspeptin administration respectively.  This 
suggests that leptin positively regulates 
kisspeptin expression.36  Reduced kisspeptin 
expression and secretion may also be 
responsible for HH seen in patients with 
obesity and type 2 diabetes.1 This is 
suggested by reduced hypothalamic KISS1 
mRNA expression in a rat model of 
diabetes, with resultant low levels in 
gonadotrophins and sex hormones, which 
were corrected with kisspeptin 
administration.37 Possible mechanisms for 
reduced kisspeptin signalling in obesity and 
diabetes include: a rise in oestrogen levels in 
obesity, which then feeds back negatively on 
kisspeptin secretion, leptin resistance, 
insulin resistance, hyperglycaemia as well as 
increased inflammation seen in diabetes.1   
 
Stress and its effect on kisspeptin 
During stress and inflammation there is 
reduced expression of kisspeptin and Kiss1r 
as well as a reduction in kisspeptin 
responsiveness, leading to reduced 
gonadotrophin levels.  This is partially 
mediated by the rise in corticotrophin 
releasing hormone and glucocorticoids.  
Moreover, stress during neonatal 
period/early stages of reproductive 
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development has been found to lead to 
reduced KISS1 mRNA levels during puberty 
with pubertal delay in rats, indicating that 
the developing kisspeptin system is 
vulnerable to immune and metabolic 
stressors.10
Kisspeptin in pregnancy and lactation 
The levels of kisspeptin, secreted from 
syncytiothrophoblast placental cells, are 
elevated in pregnancy by 7000-fold. These 
persistently high circulating levels can 
possibly cause desensitization to the 
kisspeptin stimulatory effect on 
gonadotrophin secretion, resulting in 
partially suppressed gonadotrophin levels 
during pregnancy.10 Kisspeptin in gestation 
may also be important for trophoblast 
invasion, embryo implantation and 
maintenance of pregnancy.3 Moreover, a 
reduction in responsiveness to kisspeptin 
and repression of its expression was noted 
during lactation, leading to an overall 
suppression of the HPG axis in this phase.10  
Therapeutic potential of kisspeptin 
Given the effects of kisspeptin on the 
HPG axis, it may potentially be considered 
for the treatment of some conditions which 
induce HH.  When given in hypothalamic 
amenorrhoea, kisspeptin can induce and 
increase LH pulsatility, with an increase in 
frequency and mass per pulse,38 though it 
has a lower effect on FSH.8 Exogenous 
kisspeptin induced an increase in LH and 
testosterone in type 2 diabetes patients 
suffering from HH.9 It also stimulated LH 
secretion by 2.5-fold in patients with 
neurokinin B system defects (who also 
suffer from HH due to failure to stimulate 
kisspeptin).7  Kisspeptin plays a crucial role 
in hyperprolactinaemic anovulation and the 
resultant HH. This is because kisspeptin 
neurons express prolactin receptors, leading 
to reduced kisspeptin expression in 
hyperprolactinaemia. Gonadotrophin 
secretion and ovarian cyclicity is restored on 
administration of kisspeptin.39 It can also be 
used to stimulate oocyte maturation in 
women at high risk of developing ovarian 
hyperstimulation syndrome during in-vitro 
fertilization therapy.40 On the other hand, 
kisspeptin can be used as antagonistic 
therapy (high doses and continuous 
infusions can cause KISS1R desensitisation) 
to decrease GnRH and LH pulsatility in 
polycystic ovary syndrome, early puberty 
and menopause.1 
Conclusion 
It is evident that kisspeptin-KISS1R 
signalling is crucial to promote normal 
pulsatile GnRH and gonadotrophin 
secretion. This is important for sexual 
maturation and puberty as well as normal 
reproductive function and fertility.2, 41 It may 
also have a potential role in the treatment of 
certain disorders causing HH as described 
above. 
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